KR200400376Y1 - 연옥이 내장된 패드 - Google Patents
연옥이 내장된 패드 Download PDFInfo
- Publication number
- KR200400376Y1 KR200400376Y1 KR20-2005-0023840U KR20050023840U KR200400376Y1 KR 200400376 Y1 KR200400376 Y1 KR 200400376Y1 KR 20050023840 U KR20050023840 U KR 20050023840U KR 200400376 Y1 KR200400376 Y1 KR 200400376Y1
- Authority
- KR
- South Korea
- Prior art keywords
- purgatory
- activated carbon
- carbon fiber
- paper
- nephrite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000010977 jade Substances 0.000 title abstract description 19
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 25
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000001681 protective effect Effects 0.000 claims abstract description 12
- 239000002657 fibrous material Substances 0.000 claims abstract description 4
- 229920000742 Cotton Polymers 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 16
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 6
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000000191 radiation effect Effects 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 27
- 229910052640 jadeite Inorganic materials 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000003205 diastolic effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000019901 Anxiety disease Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 101000637031 Homo sapiens Trafficking protein particle complex subunit 9 Proteins 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 102100031926 Trafficking protein particle complex subunit 9 Human genes 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000003497 sciatic nerve Anatomy 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241001519451 Abramis brama Species 0.000 description 1
- 241000272875 Ardeidae Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229910052611 pyroxene Inorganic materials 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 210000001260 vocal cord Anatomy 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
- B32B5/022—Non-woven fabric
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
구분 | 일반 패드 | 본 고안의 연옥이 내장된 패드 | |
심장박동수 HR(SaO2) | 81BPM | 76 BPM | |
혈압 | 수축기(NIBP SYS) | 127 mmHg | 128 mmHg |
MEAN(평균치) | 107 mmHg | 104 mmHg | |
DIAS(이완기) | 80 mmHg | 76 mmHg | |
산소농도 (SaO2) | 91% | 93% | |
맥박수 (Pulse) | 81BPM | 76BPM |
구분 | 일반 패드 | 본 고안의 연옥이 내장된 패드 | |
심장박동수 HR(SaO2) | 81BPM | 85 BPM | |
혈압 | 수축기(NIBP SYS) | 181mmHg | 173 mmHg |
평균치(MEAN) | 142 mmHg | 127 mmHg | |
이완기(DIAS) | 111mmHg | 110 mmHg | |
산소농도 (SaO2) | 95% | 95% | |
맥박수 (Pulse) | 83 BPM | 85 BPM |
구분 | 일반 패드 | 본 고안의 연옥이 내장된 패드 | |
심장박동수 HR(SaO2) | 68 BPM | 68 BPM | |
혈압 | 수축기(NIBP SYS) | 185 mmHg | 176 mmHg |
평균치(MEAN) | 117 mmHg | 125 mmHg | |
이완기(DIAS) | 104 mmHg | 105 mmHg | |
산소농도 (SaO2) | 74% | 96% | |
맥박수 (Pulse) | 68 BPM | 68 BPM |
순서 | 구 분 | 평가(%) |
1 | 효과가 미미하거나 없을 시 | 70%미만 |
2 | 효과가 있을 시 | 70%이상 |
3 | 상당한 효과가 있을 시 | 80%이상 |
4 | 완치에 가까운 효과가 있을 시 | 90%이상 |
효과판정질환 명 | 별무효과 | 효과있음 | 상당한 효과 | 완치근접효과 | 계 |
70%미만 | 70%이상 | 80%이상 | 90%이상 | ||
두통. 현훈 | 2 | 3 | 5 | 1 | 11 |
불 면 | 0 | 2 | 1 | 1 | 4 |
불안.흉민 | 1 | 1 | 1 | 2 | 5 |
손발 저림 | 0 | 1 | 1 | 1 | 3 |
소화 불량 | 0 | 0 | 2 | 0 | 2 |
계 | 3(12%) | 7(28%) | 10(40%) | 5(20%) | 25(100%) |
시 료 | 옥 분 |
시료성상 | 백색분말 |
작업번호 | 미합중국 F.D.A부설연구소 연방 IW 091394-1 |
방 법 | 원자흡광 분석 |
결 과 | 검출되지 않음 |
시 료 | 옥분 |
시료성상 | 백색 |
작업번호 | 연방 IW 080894-4 |
방 법 | USP 23 |
결 과 | 검출되지 않음 |
시 료 | 옥분 |
시료성상 | 백색 |
작업번호 | 연방 IW 080894-4 |
방 법 | 하기와 같음 |
결 과 | 하기와 같음 |
분석물질 | 결과(ppm) | 검출한도(ppm) |
비소(As) | ND | 0.05 |
바륨(Ba) | ND | 0.20 |
카드뮴(Cd) | 0.005 | 0.007 |
염소(Cl) | ND | 1 |
크롬(Cr) | ND | 0.01 |
구리(Cu) | ND | 0.05 |
철(Fe) | ND | 0.10 |
납(Pb) | ND | 0.05 |
망간(Mn) | ND | 0.02 |
수은(Hg) | ND | 0.0005 |
질산염(NO3) | ND | 0.1 |
셀레늄(Se) | ND | 0.05 |
은(Ag) | ND | 0.01 |
황산염(SO4) | ND | 1 |
아연(Zn) | ND | 0.01 |
<옥(玉)남자(40세) | 여자(19세) | ||
측정전 | 측정후 | 측정전 | 측정후 |
협심증(50121) | 43 | 43 | 45 |
당뇨병(10932) | 35 | 37 | 54 |
고혈압(45031) | 44 | 45 | 44 |
좌골신경(42812) | 24 | 53 | 54 |
남자(39세) | 여자(21세) | |||
측정 전 | 측정 후 | 측정 전 | 측정 후 | |
협심증(52071) | 53 | 64 | 35 | 44 |
당뇨병(11009) | 47 | 53 | 42 | 43 |
고혈압(40520) | 48 | 57 | 33 | 41 |
좌골신경(40228) | 43 | 61 | 23 | 52 |
0 ~25% | 나쁨 |
25 ~45% | 좋음 |
45 ~ 55% | 아주 좋음 |
55 ~ 75% | 좋음 |
75~ 100% | 나쁨 |
Claims (2)
- 다수개의 연옥 수납부들이 구획 형성된 소정 넓이의 부직포지;상기 부직포지의 연옥 수납부들에 넣어 봉합한 연옥부재;상기 부직포지의 어느 일측면에만 설치되어 상기 연옥부재들의 전체를 가리는 상태로 위치되어 상기 부직포지와 일체로 봉합되는 활성 탄소섬유지;상기 활성탄소섬유지와 상기 부직포지를 모두 감싸는 형태로 설치되어 상기 부직포지 및 상기 활성 탄소섬유지와 일체로 봉착되는 섬유재질의 보호지; 및상기 보호지의 전 외부를 감싸는 형태로 설치된 면 재질의 커버지를 포함하는 연옥이 내장된 패드.
- 제1항에 있어서, 상기 연옥 수납부에는 상기 연옥부재를 유동됨이 없게 고정하기 위한 부직포재질의 고정 판재들을 더 구비하고, 상기 고정판재들에는 상기 연옥부재를 유동됨이 없이 끼움 고정하기 위한 일부위가 절단된 고정구멍들이 설치됨을 특징으로하는 연옥이 내장된 패드.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20-2005-0023840U KR200400376Y1 (ko) | 2005-08-18 | 2005-08-18 | 연옥이 내장된 패드 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20-2005-0023840U KR200400376Y1 (ko) | 2005-08-18 | 2005-08-18 | 연옥이 내장된 패드 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR200400376Y1 true KR200400376Y1 (ko) | 2005-11-03 |
Family
ID=43701403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20-2005-0023840U Expired - Fee Related KR200400376Y1 (ko) | 2005-08-18 | 2005-08-18 | 연옥이 내장된 패드 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR200400376Y1 (ko) |
-
2005
- 2005-08-18 KR KR20-2005-0023840U patent/KR200400376Y1/ko not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2025041601A (ja) | バイオセラミック組成物およびその生体修飾的使用 | |
Honda et al. | Decreased exercise hyperpnea in patients with bilateral carotid chemoreceptor resection | |
CN104983558B (zh) | 一种背部理疗装置 | |
CN102600006A (zh) | 一种生物陶瓷热敷袋 | |
KR200400376Y1 (ko) | 연옥이 내장된 패드 | |
KR100279694B1 (ko) | 연옥분이 함유된 화장료와 그 제조방법 | |
CN104759035B (zh) | 一种利用兹阳石制做保健用品的方法 | |
KR200401489Y1 (ko) | 연옥이 내장된 자켓 | |
MORABAD et al. | Elemental profile analysis of some Indian traditional medicinal spice seeds of Ballari District, Karnataka using AAS technique | |
CN103251891A (zh) | 一种治疗气滞血瘀型不稳定性心绞痛的中药外用膏剂 | |
KR100326847B1 (ko) | 연옥분이 함유된 치약과 그 제조방법 | |
KR100277345B1 (ko) | 연옥 분이 함유된 피혁 지와 그 제조방법 및용도 | |
KR20160030491A (ko) | 광물가루 가공 시스템 및 그 제어방법 | |
KR100227469B1 (ko) | 휴대가능한 기상(氣相)의 연옥 흡입용 캔 | |
JP2757173B2 (ja) | 軟玉粉が含浸されたフィラメントの製造方法 | |
KR20050060112A (ko) | 연옥(軟玉)이 함유된 페인트 및 그 제조방법 | |
KR20000038283A (ko) | 연옥 분이 함유된 실리콘 고무와 그 제조방법 | |
KR20120003802A (ko) | 스코리아 부착방법 | |
KR0146158B1 (ko) | 연옥분(軟玉紛)이 함침된 스테이플 화이버 부직포의 제조방법 | |
CN2314756Y (zh) | 组合联动块式康复腰垫 | |
JP2589662B2 (ja) | 鉱物粉混合健康増進材及び健康増進具 | |
KR20010010076A (ko) | 연옥이 함유된 합성수지 시이트 및 그 제조방법 | |
CN101249242B (zh) | 一种广谱治疗胃病的中药制剂及其制备方法 | |
KR100662541B1 (ko) | 연옥이 도포된 마사 | |
KR0151794B1 (ko) | 연옥분이 함침된 필라멘트의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UA0108 | Application for utility model registration |
Comment text: Application for Utility Model Registration Patent event code: UA01011R08D Patent event date: 20050818 |
|
REGI | Registration of establishment | ||
UR0701 | Registration of establishment |
Patent event date: 20051028 Patent event code: UR07011E01D Comment text: Registration of Establishment |
|
UR1002 | Payment of registration fee |
Start annual number: 1 End annual number: 1 Payment date: 20050819 |
|
UG1601 | Publication of registration | ||
UR1001 | Payment of annual fee |
Payment date: 20061027 Start annual number: 2 End annual number: 3 |
|
FPAY | Annual fee payment |
Payment date: 20090428 Year of fee payment: 4 |
|
UR1001 | Payment of annual fee |
Payment date: 20090428 Start annual number: 4 End annual number: 4 |
|
LAPS | Lapse due to unpaid annual fee | ||
UC1903 | Unpaid annual fee |
Termination date: 20100910 Termination category: Default of registration fee |